| Literature DB >> 26602927 |
Kirsi Harju1, Marja-Leena Rapinoja2, Marc-André Avondet3, Werner Arnold4, Martin Schär5, Werner Luginbühl6, Anke Kremp7, Sanna Suikkanen8, Harri Kankaanpää9, Stephen Burrell10, Martin Söderström11, Paula Vanninen12.
Abstract
A saxitoxin (STX) proficiency test (PT) was organized as part of the Establishment of Quality Assurance for the Detection of Biological Toxins of Potential Bioterrorism Risk (EQuATox) project. The aim of this PT was to provide an evaluation of existing methods and the European laboratories' capabilities for the analysis of STX and some of its analogues in real samples. Homogenized mussel material and algal cell materials containing paralytic shellfish poisoning (PSP) toxins were produced as reference sample matrices. The reference material was characterized using various analytical methods. Acidified algal extract samples at two concentration levels were prepared from a bulk culture of PSP toxins producing dinoflagellate Alexandrium ostenfeldii. The homogeneity and stability of the prepared PT samples were studied and found to be fit-for-purpose. Thereafter, eight STX PT samples were sent to ten participating laboratories from eight countries. The PT offered the participating laboratories the possibility to assess their performance regarding the qualitative and quantitative detection of PSP toxins. Various techniques such as official Association of Official Analytical Chemists (AOAC) methods, immunoassays, and liquid chromatography-mass spectrometry were used for sample analyses.Entities:
Keywords: dinoflagellate; mussel; paralytic shellfish poisoning toxins; proficiency test; saxitoxin
Mesh:
Substances:
Year: 2015 PMID: 26602927 PMCID: PMC4690102 DOI: 10.3390/toxins7124852
Source DB: PubMed Journal: Toxins (Basel) ISSN: 2072-6651 Impact factor: 4.546
The assigned values and standard deviations for STX analyzed before the PT.
| STX PT Sample | Sample Type | STX | Method |
|---|---|---|---|
| A | algal cells on filter paper | 572 ± 75 ng/mL | LC-MS/MS |
| E1 | algal extract (1:50) | 4.7 ± 0.6 ng/mL | LC-MS/MS |
| E2 | algal extract (1:10) | 28 ± 2 ng/mL | LC-MS/MS |
| M | mussel sample | 126 ± 0.6 ng/g mussel | HPLC-FLD |
Characterization of paralytic shellfish poisoning (PSP) toxins in saxitoxin (STX) proficiency test (PT) sample material.
| Method | Algal Sample Material | Mussel Sample Material |
|---|---|---|
| PSP Analogues Identified | PSP Analogues Identified | |
| Ridascreen ELISA | PSP positive | PSP positive |
| LC-MS/MS | STX, GTX2, GTX3 | STX, dcSTX, NEO, GTX1, GTX2, GTX3 |
| pre-column HPLC-FLD | STX, GTX2&3 | STX, dcSTX, NEO, GTX1&4, GTX2&3, GTX5 |
Retention time (rt, min) and relative product ion intensities (q/Q, %) based identification of STX in algal and mussel samples either with product ion scan or multiple reaction monitoring (MRM) mode, liquid chromatography-tandem mass spectrometry (LC-MS/MS) at m/z 300.
| 6.32 ± 0.06 min | 6.31 ± 0.06 min | ±0.2 min | ||
| 266/282 | 19 ± 1 | 19 ± 2 | 18 ± 3 | 13–25 |
| 204/282 | 21 ± 1 | 22 ± 2 | 19 ± 2 | 16–26 |
| 186/282 | 9 ± 1 | 9 ± 1 | 8 ± 2 | 4–14 |
| 15.2 ± 0.1 min | 15.1 ± 0.1 min | ±0.2 min | ||
| 138/204 | 81 ± 4 | 68 ± 4 | 71 ± 6 | 65–97 |
| 282/204 | 96 ± 5 | 89 ± 3 | 94 ± 7 | 77–115 |
Finnigan LXQ; AB Sciex 3200 QTrap; STX confirmed with the reference standard addition; retention time tolerance |∆rt| ≤ 0.2 min [18]; EU criteria: compare with the relative ion intensity of the standard, q/Q >50%: tolerance ± 20%; >20% to 50%: tolerance ± 25%; >10% to 20%: tolerance ± 30%; ≤10%: tolerance ± 50% [19].
STX PT samples.
| STX PT Sample | Sample Type | Sample Amount | |
|---|---|---|---|
| A | Toxic freeze-dried algal sample on filter paper | 120 | ~350,000 cells |
| E1 | Pooled toxic algal extract (diluted 1:50) | 47 | 5.0 mL |
| E2 | Pooled toxic algal extract (diluted 1:10) | 28 | 5.0 mL |
| M | Toxic homogenized mussel sample | 100 | ~5.3 g |
Homogeneity results of STX PT samples.
| STX PT Sample | Sample Type | STX in the Sample | RSD (%) | Method | |
|---|---|---|---|---|---|
| A | Algal cells on filter paper | 15 | 654 ± 77 ng on filter | 12 | LC-MS/MS |
| E1 | Algal extract (1:50) | 10 | 4.7 ± 0.6 ng/mL | 14 | LC-MS/MS |
| E2 | Algal extract (1:10) | 10 | 28 ± 2 ng/mL | 8 | LC-MS/MS |
| M | Mussel sample | 10 | 130.7 ± 6.2 ng/g mussel | 5 | HPLC-FLD |
Figure 1Four-week stability of the PT samples at 4 °C and −20 °C during the test. (a) Algal sample, A; (b) Algal extract, E1; (c) Algal extract, E2; (d) Mussel sample, M.
Summary of PSP toxin positive samples (+) of ten participating laboratories with any method.
| STX PT Sample | Analyte | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| A | PSP toxin | + | na | + | + | + | + | + | + | + | na |
| E1 | PSP toxin | + | na | + | + | + | + | + | + | + | na |
| E2 | PSP toxin | + | na | + | + | + | + | + | + | + | na |
| M | PSP toxin | + | + | + | + | + | + | + | na | + | + |
Note: na: not analyzed.
Immunoassay results of STX PT samples, PSP positive (+) or PSP negative (–).
| Laboratory | 4 | 5 | 5 | 6 | 7 | |
|---|---|---|---|---|---|---|
| Method | Ridascreen | Ridascreen | Jellett | Jellett | Abraxis | |
| Sample | ||||||
| A | + | + | + | + | + | |
| E1 | + | + | − | − | + | |
| E2 | + | + | + | + | + | |
| M | + | + | + | + | + | |
Mouse bioassay (MBA) results of STX PT samples.
| Laboratory | 9 | 10 | |
|---|---|---|---|
| Method | MBA | MBA | |
| Sample | |||
| A | + | na | |
| E1 | no | no | |
| E2 | na | na | |
| M | na | + | |
Note: +: PSP positive; na: not analyzed; no: too dilute for MBA.
Summary of qualitative STX results obtained with LC-MS/MS, pre-column HPLC-FLD (pre), and post-column HPLC-FLD (post) methods.
| Laboratory | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Method | LC-MS/MS | pre-ox | post-ox | LC-MS/MS | LC-MS/MS | pre-ox | - | LC-MS/MS | pre-ox | - | |
| Sample | Analyte | ||||||||||
| A | STX | + | na | + | + | + | + | na | + | + | na |
| E1 | STX | + | na | + | + | + | + | na | + | + | na |
| E2 | STX | + | na | + | + | + | + | na | + | + | na |
| M | STX | + | + | + | + | + | + | na | na | + | na |
Note: +: STX positive; na: not analyzed.
Summary of qualitative results of STX analogues found with LC-MS/MS, pre-column HPLC-FLD (pre-ox), and post-column HPLC-FLD (post-ox) in the samples (laboratories 1–10).
| Laboratory | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Method | - | pre-ox | post-ox | LC-MS/MS | LC-MS/MS | pre-ox | - | LC-MS/MS | pre-ox | - | |
| Sample | Analyte | ||||||||||
| A | GTX2 | + | + | ||||||||
| GTX3 | + | + | + | ||||||||
| GTX2&3 | + | + | + | ||||||||
| E1 | GTX2 | + | + | ||||||||
| GTX3 | + | + | |||||||||
| GTX2&3 | + | + | + | ||||||||
| E2 | GTX2 | + | + | ||||||||
| GTX3 | + | + | + | ||||||||
| GTX2&3 | + | + | + | ||||||||
| M | dcSTX | + | + | + | + | + | + | ||||
| GTX2 | + | + | + | + | |||||||
| GTX3 | + | + | + | ||||||||
| GTX2&3 | + | + | |||||||||
| GTX1 | + | + | |||||||||
| GTX4 | + | ||||||||||
| GTX1&4 | + | + | |||||||||
| NEO | + | + | + | + | + | ||||||
| GTX5 | + | + | |||||||||
Summary of reported STX concentrations, assigned values Xa (nominal), their standard and relative standard uncertainties and the standard deviations of the proficiency assessment.
| Sample | µ | σ | Unit | CV | Xa | u(Xa) | urel(Xa) (%) | σp | |
|---|---|---|---|---|---|---|---|---|---|
| A1 | 621.7 | 276.4 | ng STX/filter | 8 | 0.445 | 572 | 19.4 | 3.4 | 145.9 |
| A2 | 522.0 | 217.8 | ng STX/filter | 8 | 0.417 | 572 | 19.4 | 3.4 | 145.9 |
| A3 | 609.6 | 309.4 | ng STX/filter | 8 | 0.508 | 572 | 19.4 | 3.4 | 145.9 |
| E1 | 8.3 | 4.8 | ng STX/mL | 7 | 0.578 | 4.7 | 0.2 | 4.0 | 1.2 |
| E2 | 30.0 | 13.7 | ng STX/mL | 8 | 0.455 | 28 | 0.6 | 2.3 | 7.1 |
| M1 | 106.9 | 59.9 | ng STX/g of mussel | 6 | 0.560 | 126 | 0.3 | 0.3 | 32.1 |
| M2 | 117.5 | 69.3 | ng STX/g of mussel | 6 | 0.590 | 126 | 0.3 | 0.3 | 32.1 |
| M3 | 97.4 | 54.4 | ng STX/g of mussel | 6 | 0.559 | 126 | 0.3 | 0.3 | 32.1 |
Note: µ = mean of participants’ results as estimated by robust statistics; σ = standard deviation of participants’ means; n = number of mean results; CV = coefficient of variation (σ/µ); Xa = assigned value; u(Xa) = standard uncertainty of the assigned value; urel(Xa) = relative standard uncertainty of the assigned value, u(Xa)/Xa (%); σp = estimated standard deviation for proficiency assessment.
Figure 2Graphical overview of the quantitative results of STX by normal probability plots of z-scores for A, E1–E2, and M. Participating laboratories 1–9, methods: LC-MS/MS (L), HPLC-FLD pre-column (HR) and post-column (HO).
Figure 3Effect of methods on the average quality of quantitation of STX, all samples, all methods, as assessed by the z-score means. Error bars represent ± 1 SD. Number of results: HPLC-FLD/post = 24, HPLD-FLD/pre = 56, LC-MS/MS = 75.
Figure 4Effect of sample matrix on the average quality of quantitation of STX, all samples, all methods, as assessed by the z-score means. The dotted lines represent ±2 z-score values and the error bars represent ±1 standard error.
Concentrations of PSP toxins ng/g in mussel sample M.
| ng/g Mussel | dcSTX | NEO | GTX1 | GTX4 | GTX1&4 | GTX2 | GTX3 | GTX2&3 | GTX5 |
|---|---|---|---|---|---|---|---|---|---|
| Ref. Lab 1 a | 169 ± 8 | 55 ± 3 | na | na | 316 ± 13 | na | na | 346 ± 24 | 2.9 ± 0.1 |
| Ref. Lab 2 b | 194 ± 7 | nq | na | na | 430 | na | na | 515 ± 31 | 35 |
| 15 | 15 | 6 | 3 | 6 | 6 | 6 | 6 | 6 | |
| mean | 191 | 157 | 257 | 68 | 704 | 443 | 88 | 555 | 32 |
| SD | 66 | 154 | 118 | 3 | 409 | 161 | 15 | 40 | 5 |
| CV% | 35 | 98 | 46 | 4 | 58 | 36 | 17 | 7 | 16 |
Note: a Marine Institute; b SPIEZ LABORATORY; na: not analyzed; nq: not quantified; n: number of results.
Gonyautoxin 2 (GTX2) and gonyautoxin 3 (GTX3) results in algal sample A (reference value ~4000 ng/filter for GTX2>X3 measured with HPLC-FLD).
| PSP Analogue | GTX2 | GTX3 | GTX2&3 | |
|---|---|---|---|---|
| 6 | 9 | 6 | ||
| mean | 1232 | 3803 | 3601 | |
| SD | 415 | 850 | 1639 | |
| CV% | 34 | 22 | 46 | |
GTX2 and GTX3 results in E1 (reference value ~40 ng/mL for GTX2>X3 measured with HPLC-FLD).
| PSP Analogue | GTX2 | GTX3 | GTX2&3 | |
|---|---|---|---|---|
| 2 | 2 | 2 | ||
| mean | 37 | 44 | 51 | |
| SD | 13 | 25 | 3 | |
| CV% | 37 | 58 | 6 | |
GTX2, and GTX3 results in E2 (reference value ~200 ng/mL for GTX2 & GTX3, measured with HPLC-FLD).
| PSP Analogue | GTX2 | GTX3 | GTX2&3 | |
|---|---|---|---|---|
| 2 | 3 | 2 | ||
| mean | 92 | 216 | 214 | |
| SD | 6 | 75 | 121 | |
| CV% | 6 | 35 | 57 | |